Lam F, Guru S, AbuReesh D, Hori Y, Chuang C, Liu L
Brain Sci. 2025; 15(2).
PMID: 40002531
PMC: 11852773.
DOI: 10.3390/brainsci15020199.
Coles-Black J, Rahman A, Siva S, Ischia J, Perera M, Bolton D
Life (Basel). 2025; 14(12.
PMID: 39768390
PMC: 11678295.
DOI: 10.3390/life14121683.
Anand A, Kakkar N, Immanuel V, Pannu J, Chaudhoory A, Malhotra H
BJR Open. 2024; 6(1):tzae042.
PMID: 39659868
PMC: 11630083.
DOI: 10.1093/bjro/tzae042.
Tanimoto Y, Oita M, Koshi K, Ishiwaki K, Hiramatsu F, Sasaki T
Radiol Phys Technol. 2024; 18(1):78-85.
PMID: 39557763
PMC: 11876268.
DOI: 10.1007/s12194-024-00857-z.
Lin Y, Qureshi M, Batra S, Truong M, Mak K
Adv Radiat Oncol. 2024; 9(12):101625.
PMID: 39524524
PMC: 11550745.
DOI: 10.1016/j.adro.2024.101625.
The Role of CT and MR Imaging in Stereotactic Body Radiotherapy of the Spine: From Patient Selection and Treatment Planning to Post-Treatment Monitoring.
Azadbakht J, Condos A, Haynor D, Gibbs W, Jabehdar Maralani P, Sahgal A
Cancers (Basel). 2024; 16(21).
PMID: 39518130
PMC: 11545634.
DOI: 10.3390/cancers16213692.
Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients.
Deng B, Kong W, Han C, Zhou C, Li J, Song D
Int J Med Sci. 2024; 21(10):2000-2010.
PMID: 39113881
PMC: 11302553.
DOI: 10.7150/ijms.95900.
Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?.
Saude-Conde R, El Ghali B, Navez J, Bouchart C, Van Laethem J
Cancers (Basel). 2024; 16(13).
PMID: 39001485
PMC: 11240662.
DOI: 10.3390/cancers16132423.
Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer.
Chlorogiannis D, Moussa A, Zhao K, Alexander E, Sofocleous C, Sotirchos V
Diagnostics (Basel). 2024; 14(7).
PMID: 38611685
PMC: 11011364.
DOI: 10.3390/diagnostics14070772.
When radiation meets the heart: Future of stereotactic body radiation therapy for hypertrophic obstructive cardiomyopathy.
Liao L, Tang H, Hu L, Zhou S, Li X
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 48(12):1914-1919.
PMID: 38448385
PMC: 10930745.
DOI: 10.11817/j.issn.1672-7347.2023.230249.
Quality Assurance for Stereotactic Body Radiation Therapy for Gynecologic Malignancies.
Andersen S, Bonnen M, Ludwig M, Dalwadi S
Cureus. 2024; 16(2):e53470.
PMID: 38435154
PMC: 10909451.
DOI: 10.7759/cureus.53470.
NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies.
Liu W, Feng H, Taylor P, Kang M, Shen J, Saini J
Int J Radiat Oncol Biol Phys. 2024; 119(4):1208-1221.
PMID: 38395086
PMC: 11209785.
DOI: 10.1016/j.ijrobp.2024.01.216.
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective.
Bonu M, Nicosia L, Turkaj A, Pastorello E, Vitali P, Frassine F
Radiol Med. 2024; 129(3):497-506.
PMID: 38345714
PMC: 10942931.
DOI: 10.1007/s11547-024-01788-w.
Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings.
Starling M, Thibodeau S, de Sousa C, Restini F, Viani G, Gouveia A
Cancers (Basel). 2024; 16(3).
PMID: 38339290
PMC: 10854666.
DOI: 10.3390/cancers16030539.
MR-LINAC, a New Partner in Radiation Oncology: Current Landscape.
Ocanto A, Torres L, Montijano M, Rincon D, Fernandez C, Sevilla B
Cancers (Basel). 2024; 16(2).
PMID: 38254760
PMC: 10813892.
DOI: 10.3390/cancers16020270.
Stereotactic body radiotherapy for early-stage lung cancer: a systematic review on the choice of photon energy and linac flattened/unflattened beams.
Gill A, Hirst A, Rowshanfarzad P, Gill S, Bucknell N, Dass J
Radiat Oncol. 2024; 19(1):1.
PMID: 38167095
PMC: 10762943.
DOI: 10.1186/s13014-023-02392-4.
Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma.
Raj R, Upadhyay R, Wang S, Singer E, Dason S
Curr Oncol. 2023; 30(12):10283-10298.
PMID: 38132383
PMC: 10742565.
DOI: 10.3390/curroncol30120749.
Stereotactic body proton therapy for early stage non-small cell lung cancer - Technical challenges and solutions: The MD Anderson experience.
Zhu X, Li Y, Yang M, Whitaker T, Taylor P, Zhang X
J Radiosurg SBRT. 2023; 9(1):75-82.
PMID: 38029015
PMC: 10681148.
Challenges and opportunities in stereotactic body proton radiotherapy of liver malignancies.
Li H, Ger R, Narang A, Chen H, Meyer J
J Radiosurg SBRT. 2023; 9(1):83-90.
PMID: 38029013
PMC: 10681149.
An optimal method of hydrogel spacer insertion for stereotactic body radiation therapy of prostate cancer.
Kobayashi H, Eriguchi T, Tanaka T, Ogata T, Osaki N, Suzuki H
Jpn J Radiol. 2023; 42(4):406-414.
PMID: 37932639
DOI: 10.1007/s11604-023-01506-y.
